Literature DB >> 31531174

The Safe and Efficacious Use of Secretome From Fibroblasts and Adipose-derived (but not Bone Marrow-derived) Mesenchymal Stem Cells for Skin Therapeutics.

Greg Maguire1.   

Abstract

Stem cell-based products are rapidly emerging in the marketplace as topical skin care and wound care products. Confusion is prevalent among healthcare providers and end-users about these products. Adipose-derived stem cells, fibroblasts, platelets, and bone marrow-derived stem cells are the most common cells used for stem cell therapeutic development, medical procedures, and skin care products. In this review, the significant advantages of adipose-derived stem cells and fibroblasts in terms of safety and efficacy are highlighted and compared to relatively risky platelets and bone marrow stem cells.

Keywords:  Cancer; fibroblasts; inflammation; platelets; secretome; stem cells

Year:  2019        PMID: 31531174      PMCID: PMC6715117     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  7 in total

Review 1.  Adipose-derived stem cell secretome as a cell-free product for cutaneous wound healing.

Authors:  Amita Ajit; Indu Ambika Gopalankutty
Journal:  3 Biotech       Date:  2021-08-16       Impact factor: 2.893

2.  Development of secretome-based strategies to improve cell culture protocols in tissue engineering.

Authors:  O Cases-Perera; C Blanco-Elices; J Chato-Astrain; C Miranda-Fernández; F Campos; P V Crespo; I Sánchez-Montesinos; M Alaminos; M A Martín-Piedra; I Garzón
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

3.  The safety of a therapeutic product composed of a combination of stem cell released molecules from adipose mesenchymal stem cells and fibroblasts.

Authors:  Greg Maguire; Peter Friedman
Journal:  Future Sci OA       Date:  2020-05-29

4.  Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes.

Authors:  Greg Maguire; Christy Eubanks; George Ayoub
Journal:  Neuronal Signal       Date:  2022-02-16

Review 5.  Advances in lncRNAs from stem cell-derived exosome for the treatment of cardiovascular diseases.

Authors:  Jiahui Ma; Pengyu Lei; Haojie Chen; Lei Wang; Yimeng Fang; Xiaoqing Yan; Qinsi Yang; Bo Peng; Libo Jin; Da Sun
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

6.  Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis.

Authors:  Tadeu Diniz Ramos; Johnatas Dutra Silva; Alessandra Marcia da Fonseca-Martins; Juliana Elena da Silveira Pratti; Luan Firmino-Cruz; Diogo Maciel-Oliveira; Julio Souza Dos-Santos; João Ivo Nunes Tenorio; Almair Ferreira de Araujo; Célio Geraldo Freire-de-Lima; Bruno Lourenço Diaz; Fernanda Ferreira Cruz; Patricia Rieken Macedo Rocco; Herbert Leonel de Matos Guedes
Journal:  Stem Cell Res Ther       Date:  2020-08-31       Impact factor: 6.832

Review 7.  Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration.

Authors:  Dae Hyun Ha; Hyun-Keun Kim; Joon Lee; Hyuck Hoon Kwon; Gyeong-Hun Park; Steve Hoseong Yang; Jae Yoon Jung; Hosung Choi; Jun Ho Lee; Sumi Sung; Yong Weon Yi; Byong Seung Cho
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.